US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Nov. 4 for "Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use" (Maryland, Pennsylvania Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,683, issued on Nov. 4, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use" was invented by Michael J. Lenardo (Bethesda, Md.), Jian Li (Rockville, Md.), Lixin Zheng (Rockville, Md.), Jae W. Lee (Philadelphia) and Wei Lu (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a protein comprising no more than three human autoantigenic proteins, wherein a first human autoantigenic protein comprises a truncated myelin oligodendrocyte gl...